Reimagining Antibody-Based Radiopharmaceuticals: Using Click-to-Release Technology to Expand the Therapeutic Window Across Multiple Targets
Targeted Radiopharmaceuticals Summit EU 2026 · 3 December 2026 · 11:30
Reimagining Antibody-Based Radiopharmaceuticals: Using Click-to-Release Technology to Expand the Therapeutic Window Across Multiple Targets was a session at Targeted Radiopharmaceuticals Summit EU 2026 on 3 December 2026 in London, with 1 speaker on record.
Speakers
- Marc Robillard — Speaker Chief Scientific Officer & Founder, Tagworks Pharmaceuticals BV